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The complex N-AcPhe-tRNAPhe’poly(U).80 S ribosome from human placenta was treated with puromycin taken in various concentrations. Based 
on the kinetic data of N-acetylphenylalanyl-puromycin formation, the association constant of puromycin with the acceptor site of the ribosome 
was estimated to be (3.96 + 0.84) x IW M-r at 37°C. 
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1. INTRODUCTION 
One of the essential functions of ribosomes in the 
course of translation is peptidyl transfer. All types of 
ribosomes perform this reaction in the same way - 
without using protein factors or nucleoside triphos- 
phates; peptidyltransferase center is located on large 
ribosomal subunit [ 11. Antibiotic puromycin imitating 
the 3 ‘-end of aminoacyl-tRNA is widely used for in- 
vestigation of tRNA-ribosome interactions and pepti- 
dyltransferase center as it accepts polypeptide chain or 
aminoacyl residue attached to tRNA being located in 
peptidyl (P) site of ribosome (for review see [2]). 
Puromycin reaction is common for P-site-bound pep- 
tidyl-tRNA in all classes of ribosomes, so affinity of 
puromycin as minimal acceptor substrate to the ribo- 
somal peptidyltransferase center reflects properties of 
this center. 
Puromycin affinity to E. cofi ribosomes was studied 
earlier [3-51 whereas parameters of puromycin interac- 
tion with eucaryotic ones were not measured. Here we 
have calculated the association constant of puromycin 
with human placenta 80 S ribosomes using the kinetic 
data on N-AcPhe-puromycin formation at 37°C at 
various puromycin concentrations. 
2. MATERIALS AND METHODS 
40 S and 60 S ribosomal subunits were isolated from normal full- 
term human placenta according to [6]. Enriched preparation of 
[‘?]Phe-tRNAPh’ from E. co/i (1700 pmol/A26o unit) was prepared 
as in [7]. N-Ac[%]Phe-tRNAPhC (1500 pmol/AZGo unit) was syn- 
thesized according to [8]. Poly(U) was purchased from Reanal 
(Hungary), puromycin from Fluka. 
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TO obtain 80 S ribosomes, 40 S and 60 S subunits were re-activated 
by incubation in buffer A (0.013 M MgClz, 0.12 M KCI, 0.006 M ED- 
TA, 0.02 M Tris-HCl, pH 7.5) at 37°C for 10 min and mixed in a 
molar ratio 40 S/60 S = 1: 1.3 (assuming that 1 A260 unit corresponds 
to 50 pmol of 40 S, or 25 pmol of 60 S subunits [9]). Binding of N- 
AcPhe-tRNAPhe and poly(U) to 80 S ribosomes was performed by in- 
cubation of the components in buffer A at 20°C for 15 min. The con- 
centrations of 80 S ribosomes, N-Ac[‘4C]Phe-tRNAPhC and poly(U) 
were 4.2 x lo-’ M; 1.6 x IO-’ M and 2.3 AzhO units/ml, respective- 
ly. After the incubation, puromycin was added to the reaction mix- 
tures and temperature was raised up to 37°C. Aliquots were removed 
from the mixtures, diluted with 15 vols of 0.1 M NaAc, pH 5 .O, and 
the amount of N-Ac[‘4C]Phe-puromycin formed was determined by 
extraction into ethylacetate according to [lo]. The kinetic data were 
processed on an Apple II personal computer with the help of non- 
linear regression program [ 111. 
3. RESULTS AND DISCUSSION 
Activity of 80 S ribosomes was tested by non- 
enzymatic poly(U)-dependent binding of [ 14C]Phe- 
tRNAPhe and accompanying diphenylalanine formation 
as in [12]. Under conditions of saturation of the 
ribosomes with Phe-tRNAPhe (at a more than 5-fold ex- 
cess of tRNA with respect to ribosomes), the binding 
level was about 0.7 mol of the Phe-tRNAPhe per mol of 
ribosomes; the level of (Pheh formation was about 0.3 
mol per mol of ribosomes. Thus under saturating con- 
ditions, both A and P sites of the active fraction of 
ribosomes are occupied by Phe-tRNAPhe and about 
35% of the ribosomes are active in this binding. Also, 
it is evident that almost all ribosomes that are active in 
Phe-tRNAPH’ binding are competent in pep- 
tidyltransferase reaction. 
For N-AcPhe-puromycin synthesis to be performed, 
N-AcPhe-tRNAPhe should be bond at a ribosomal 
donor (peptidyl, P) site. Upon non-enzymatic binding 
the affinity of N-AcPhe-tRNAPh’ to the P site is higher 
than to the A site on E. coli 70 S ribosomes [13]. 
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Fig. 1. Kinetic curves of N-Ac[%]Phe-puromycin formation upon 
treatment of the complex N-Ac[‘4C]Phe-tRNAPhe.poly(U).80 S 
ribosome with different concentrations of puromycin at 37°C. (1) 130 
$vl puromycin (for 400 pM puromycin the same curve was obtained, 
not shown in this figure); (2) 67 pM; (3) 40 PM; (4) 23 FM; (5) 7.5 PM. 
The extent of N-Ac[%]Phe-tRNAPhe binding was 0.24 (without 
template below 0.01) mol per mol of ribosomes. 
Therefore the tRNA derivative should preferentially 
bind at the P site under conditions of the absence of an 
excess of tRNA to ribosomes (see section 2). As seen 
from Fig. 1, all N-AcPhe-tRNAPh’ bound to the 
ribosomes is puromycin-reactive, i.e. is bound at the P 
site. To estimate association constant of puromycin 
with the acceptor site of the peptidyhransferase center 
(Kr,) the rates of IV-AcPhe-puromycin formation were 
measured under treatment of the complex N-AcPhe- 
tRNAPhe . poly(U)* 80 S ribosome with different concen- 
trations of puromycin. 
The mechanism of N-AcPhe-puromycin formation is 
described by the kinetic scheme: 
RT + P * RTP E;p 
RTP-+RT’+Z k 
where RT is the complex N-Ac[r4C]Phe- 
tRNAPhe. poly(U)-80 S ribosome; P, puromycin; RTP, 
Table I 
The values of kerr at different puromycin concentrations 
zomycin ($M) keff (min _ ‘) 
-5s 0.034 rt 0.001 
23 0.067 * 0.003 
40 0.087 i 0.017 
67 0.122 It 0.009 
130 0.134 f 0.024 
400 0.134 t 0,024 _I 
complex of RT with puromycin; RT’ the complex 80 S 
ribosome * tRNAPhe -poly(U); 2, N-AcPhe-puromycin; 
k, rate constant of N-AcPhe-puromycin formation. 
Under quasi-equilibrium conditions and in the case 
when the initial concentration of puromycin @o) is 
much higher than the concentration of RT (ro), the time 
course of the product formation can be described by the 
expression: 
[Z] = r0.D - exp(-k,ffbt)l, 
where 
keff = k.K,*po/(l f K:p.po) 
(1) 
(2) 
According to these equations the association constant 
Kp may be determined from the dependence of kerr on 
puromycin concentration. The kinetics of the product 
formation at various puromycin concentrations was in- 
vestigated for this purpose (see Fig. 1). The values of k 
and & calculated from these data according to Eqn 2 
are equal to (0.152 + 0.009) min-’ and (3.96 4 0.84) 
x IO4 M - ‘, respectively. 
It should be noted that k;, value estimated indirectly 
may differ from the real value due to cooperative ef- 
fects in the peptidyltransferase center [14]. But the ef- 
fects of positive cooperativity upon binding of donor 
substrates and puromycin were observed on E. coii 
ribosomes under specific conditions (binding at 0°C in 
the presence of 40% ethanol) and were relatively weak 
1141 or not observed at all in another work from the 
same laboratory [I 51. So we may conclude that Kr, 
estimated here should not differ significantly from the 
reaI value. Moreover, data on ‘fragment reactions’ in- 
dicate that parameters of transpeptidation reaction do 
not depend on the nature of amino acid residue involv- 
ed [ 161. Hence, using of a single type of peptidyl-tRNA 
analogue (AcPhe-tRNAPhe) is sufficient for the correct 
estimation of Kp value. 
The obtained Kp value is higher than the reported 
earlier association constants of puromycin with E. coli 
ribosomes estimated to be in the range of 103-104 at 0°C 
[3-5,171. UnfortunateIy, since there are no data on the 
parameters of puromycin interaction with E. co/i 
ribosomes under physiological conditions (at 37°C and 
in the absence of organic solvents such as alcohols) we 
cannot directly compare the Kp values for E. coli and 
human ribosomes. The knowledge of the association 
constant of puromyein makes it possible to study af- 
finities of different inhibitors of peptidyltransferase 
center (e.g. alkaloids [12]) to eucaryotic ribosomes and 
to investigate possible cooperative effects upon binding 
of acceptor and donor substrates at ribosomal pep- 
tidyltransferase center (141. 
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